A multiplex rapid diagnostic test that simultaneously detects COVID-19, Influenza A and B, respiratory syncytial virus (RSV), and adenovirus (ADV). This combination POCT product enables comprehensive respiratory pathogen screening in a single test.
Manufactured by
Shanghai, China
The two Production Plants of Shanghai Chemtron Biotech Co., Ltd. are located in the International Medical Park, Zhangjiang Development Zone, Pudong New District and Xiasha Town, Pudong New District in Shanghai. Chemtron was founded in January 2001, a high-tech enterprise in Shanghai, a vice president unit of the medical laboratory industry branch of the health industry management association, and a patent demonstration enterprise in Shanghai. Chemtron specializes in R D, production, sales and services of in-vitro rapid detection of diagnostic reagents. Chemtron has Production Plants over 17000 square meters with facilities for advanced R D, production, quality inspection equipment and instruments of in-vitro diagnostic reagent with an annual production capacity of 320 million. In San Diego, California, the United States, Chemtron (U.S.) company has established a sole-owned product development center and production plant. At present, there are 194 employees, 110 with Bachelor s degree or above including 3 Doctors, 10 Masters, accounting for 52.9% of the total employees of the company. In 2004, Chemtron passed the international certification of ISO13485 authoritative quality system; in March 2005, Chemtron passed the GMP certification of the State Food and drug administration; in 2009, it was listed in the biomedical industrialization project of Shanghai government; Chemtron s main products obtained the CE certificate in EU; 12 drug testing products series have obtained the FDA certification of the United States. Chemtron has established a first-class “Chemtron R D technology center” in the United States and China. Based on the platform of monoclonal antibody technology and laboratory medicine technology, Chemtron has speeded up the R D and marketing of its products. Chemtron has continuously developed and launched fast, sensitive, specific and accurate in-vitro diagnostic products. Chemtron now has a series of in-vitro diagnostic reagents under the national registered trademark Chemtrue , with a total of 6 series of products of more than 40 varieties: such as drug detection; tumor detection; infectious disease detection; cardiovascular disease detection; hormone detection and POCT rapid quantitative intelligent instrument with supporting CRP, HCG, MAU, cTnI, myocardial infarction three-in-one, PCT, D2 polymer and other products. Chemtron has always adhered to the business philosophy of quality, reputation, service and sincerity and the quality policy of perfect quality, standardized management, innovation and sincere service . Chemtron s products are sold to over 70 countries and regions around the world, such as the United States, Russia, Europe, South America, Middle East, East Asia, etc. Chemtron is willing to work together with you to relieve human suffering!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hangzhou Fanttest Biotech Co., Ltd.
China · 3 relevant products
Hangzhou AllTest Biotech Co.,Ltd
China · 9 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 5 relevant products
Biopanda Reagents
United Kingdom · 5 relevant products
Goldsite Diagnostics Inc.
China · 2 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 9 relevant products
Reagen Inc.
United States · 4 relevant products
Hangzhou Realy Tech Co., Ltd
China · 2 relevant products
POCBio (Nexlab Co., Ltd.)
China · 2 relevant products
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 118 closest product alternatives
Hangzhou Fanttest Biotech Co., Ltd. · China
A comprehensive rapid antigen test kit that detects COVID-19, RSV, Adenovirus, Influenza A, and Influenza B simultaneously. This multiplex test provides rapid diagnosis of five common respiratory pathogens in one test.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid antigen test for simultaneous detection of SARS-CoV-2, Influenza A+B, and respiratory syncytial virus. This test provides comprehensive assessment for major respiratory viral infections.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid diagnostic test that detects antigens for SARS-CoV-2, Influenza A+B, RSV, and Adenovirus in a single test.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplex antigen rapid test that detects four major respiratory pathogens—Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), and SARS-CoV-2—from a single sample. This expanded combo test provides comprehensive respiratory disease diagnosis.
Hangzhou Fanttest Biotech Co., Ltd. · China
A multiplex antigen test kit that simultaneously detects COVID-19, RSV, and Influenza A&B pathogens. This combo kit enables rapid identification of multiple respiratory infections from a single sample.
Biopanda Reagents · United Kingdom
A qualitative lateral flow immunochromatographic assay for detection of SARS-CoV-2, Influenza A+B, Respiratory Syncytial Virus (RSV), Adenovirus, and M. pneumoniae antigens in nasopharyngeal swab samples. This multiplex test assists in the diagnosis of multiple respiratory infections in conjunction with other diagnostic methods.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid antigen test for simultaneous detection of five respiratory pathogens including SARS-CoV-2, influenza, RSV, adenovirus, and M. pneumoniae. This comprehensive test supports rapid differential diagnosis of respiratory infections.
Goldsite Diagnostics Inc. · China
Multiplex antigen test simultaneously detecting SARS-CoV-2, Influenza A/B, and RSV from a single patient sample. Enables rapid point-of-care diagnosis of common respiratory pathogens for clinical and emergency settings.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid diagnostic test kit for simultaneous detection of six respiratory pathogens including COVID-19, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus (AdV), and Mycoplasma pneumoniae (MP). Enables comprehensive respiratory virus screening in one test.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid diagnostic test kit designed to simultaneously detect antigens for six respiratory viruses: COVID-19, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus (AdV), and Human Metapneumovirus (hMPV). This combo test provides efficient multi-pathogen screening in a single test procedure.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A lateral flow immunoassay test kit for simultaneous detection of SARS-CoV-2, influenza A and B, adenovirus (ADV), and respiratory syncytial virus (RSV) antigens. This comprehensive combo test covers major respiratory pathogens.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplex rapid antigen detection test that simultaneously identifies Influenza A, Influenza B, and SARS-CoV-2 from a single sample. This combo test provides comprehensive respiratory pathogen screening at the point of care.
106 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products